Clinical Trial Update: Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating metronomic dosing of a three-drug combination (trabectedin, gemcitabine, and dacarbazine) for leiomyosarcoma/soft tis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leiomyosarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• DTIC-Dome (dacarbazine)
• Gemzar (gemcitabine)
• Yondelis (trabectedin)

Snippet

Sponsor: Sarcoma Oncology Research Center, LLC | Conditions: Leiomyosarcoma | Phase 2 | Status: RECRUITING